Search research articles
Contact Us
Filters
Showing results (31-40 of 89) with videos related to
Page
of 9
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
October 19, 2018
Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas
Xiudong Guan, Lanxin Luo, Gulnaz Begum, et al.
Molecular Imaging and Biology
|
September 19, 2019
Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody
Shubhanchi Nigam, Lauren McCarl, Rajeev Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2009
Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines
Ryo Ueda, Mitsugu Fujita, Xinmei Zhu, et al.
Cell Death & Disease
|
September 29, 2018
Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
Xiudong Guan, Md Nabiul Hasan, Gulnaz Begum, et al.
ACS Omega
|
March 9, 2026
[<sup>64</sup>Cu]Cu-Labeled αCD11b Diabody as a Novel PET Tracer for the Detection of Immunosuppression in Glioblastoma
Bo Li, Sydney A Jackson, Amelia Stepniak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2010
Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans
Mitsugu Fujita, Michael E Scheurer, Stacy A Decker, et al.
Molecular Therapy Oncolytics
|
September 23, 2021
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment
Joseph W Jackson, Bonnie L Hall, Marco Marzulli, et al.
Journal of Translational Medicine
|
February 20, 2010
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
Kotaro Sasaki, Gary Kohanbash, Aki Hoji, et al.
Cancer Research
|
February 5, 2009
Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10
Mitsugu Fujita, Xinmei Zhu, Ryo Ueda, et al.
Molecular Systems Biology
|
November 27, 2016
Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas
Sören Müller, Siyuan John Liu, Elizabeth Di Lullo, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 89) with videos related to
Sort By:
Page
of 9
Journal of Experimental & Clinical Cancer Research : CR
|
October 19, 2018
Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas
Xiudong Guan, Lanxin Luo, Gulnaz Begum, et al.
Molecular Imaging and Biology
|
September 19, 2019
Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody
Shubhanchi Nigam, Lauren McCarl, Rajeev Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2009
Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines
Ryo Ueda, Mitsugu Fujita, Xinmei Zhu, et al.
Cell Death & Disease
|
September 29, 2018
Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
Xiudong Guan, Md Nabiul Hasan, Gulnaz Begum, et al.
ACS Omega
|
March 9, 2026
[<sup>64</sup>Cu]Cu-Labeled αCD11b Diabody as a Novel PET Tracer for the Detection of Immunosuppression in Glioblastoma
Bo Li, Sydney A Jackson, Amelia Stepniak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2010
Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans
Mitsugu Fujita, Michael E Scheurer, Stacy A Decker, et al.
Molecular Therapy Oncolytics
|
September 23, 2021
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment
Joseph W Jackson, Bonnie L Hall, Marco Marzulli, et al.
Journal of Translational Medicine
|
February 20, 2010
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
Kotaro Sasaki, Gary Kohanbash, Aki Hoji, et al.
Cancer Research
|
February 5, 2009
Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10
Mitsugu Fujita, Xinmei Zhu, Ryo Ueda, et al.
Molecular Systems Biology
|
November 27, 2016
Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas
Sören Müller, Siyuan John Liu, Elizabeth Di Lullo, et al.
Page
of 9